DUBLIN, Feb. 19, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/bs2q3x/global_liquid) has announced the addition of the "Global Liquid Biopsy Market Outlook to 2020" report to their offering.
The global liquid biopsy industry is expected to cross US$ 1 Billion mark by the end of 2020, as new products, especially those in the advanced stage of clinical studies or with pending approvals, might enter the market to support the development.
The recent discovery of liquid biopsy technology and its wide applicability have sparked off a lot of interest among researchers along with the commercial players. Owing to the same, there are numerous clinical trials being organized all over the world in order to assess the potential of liquid biopsy in various fields such as cancer, prenatal screening and organ transplant monitoring.
According to this new research report Global Liquid Biopsy Market Outlook to 2020, a major focus has been on the development of innovative products based on different technologies and different sample types. In this context, the study provides present and future outlooks for the two broad categories of liquid biopsy market; by technology and by sample type.
The former comprises of the three marker categories that dominate liquid biopsy today: Circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes). On the other hand, the latter includes the two major bodily fluid samples: blood and urine.
According to report, blood is the most widely used sample type, and is expected to remain the largest market based on sample type in the coming years as well. The report also includes a detailed pipeline analysis of upcoming liquid biopsy products along with the sample type utilized.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Liquid Biopsy - An Introduction
4. Market Dynamics
5. Global Liquid Biopsy Market Outlook to 2020
6. Global Liquid Biopsy Market Size by Technology
7. Global Liquid Biopsy Market Size by Sample Type
8. Global Liquid Biopsy Market Size by Geography
9. Pipeline Analysis
10. Key Player Analysis
- ANGLE plc
- Biocartis
- Biocept, Inc.
- Circulogene Theranostics
- Clearbridge BioMedics Pte Ltd
- Cynvenio Biosystems, Inc.
- Exosome Diagnostics, Inc.
- Guardant Health, Inc.
- MDxHealth
- NeoGenomics, Inc.
- Pathway Genomics
- Personal Genome Diagnostics
- RainDance Technology
- Trovagene, Inc.
For more information visit
http://www.researchandmarkets.com/research/bs2q3x/global_liquid
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
